Company Profile
Ningbo BestDrug is a pharmaceutical company known for its mission to discover, develop and deliver innovative pharmaceutical solutions to our business partners that help patients overcome illnesses. We are committed to bringing featured health care products, optimizing manufacturing process, and providing meaningful support for our OEM/ODMs. At Ningbo BestDrug, its strategy combines the resources of a mature pharmaceutical company with the entrepreneurial spirit and agility of a leading-edge biotech company. We focus on our customers’ needs, giving top priority to accelerating pipeline development, delivering sales growth and continuing to manage costs.Our CommitmentTo our partners and customers, employees, environment and other stakeholders, we operate with effective governance and the highest standards of ethical behavior. We seek transparency and dialogue with our stakeholders to improve our understanding of their needs. We take our commitment to economic, social and environmental sustainability seriously, and extend this expectation to our partners and suppliers. With our strength in the research and development of new medicines, we are able to design the most cost-effective manufacturing process from drug synthesis to impurties analysis.Our ProductsWe have an industry-leading portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas. Our product lines include: synthetic drugs, dietary supplement, and active ingredients in cosmetics and skin care. We own multiple innovative patents, our research team participated in various national and local R&D projects, we have long-term business relationships with many leading pharmaceutical companies.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline |
Isoquinoline,1,2,3,4-tetrahydro-1-phenyl-,(1S)-;Isoquinoline,1,2,3,4-tetrahydro-1-phenyl-,(S)-;(1S)-1,2,3,4-Tetrahydro-1-phenylisoquinoline;(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(+)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(S)-(+)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(-)-(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline;(S)-1,2,3,4-Tetrahydro-1-phenylisoquinoline |
118864-75-8 | Inquiry | |
1,4-Butanedisulfonicacid |
1,4-Butanedisulfonic acid;1,4-Disulfobutane |
27665-39-0 | Inquiry | |
1-(2-hydroxyethyl)-2-imidazolidinone |
2-Imidazolidinone,1-(2-hydroxyethyl)-;1-(2-Hydroxyethyl)-2-imidazolidinone;N-(2-Hydroxyethyl)imidazolidone;1-(Hydroxyethyl)ethyleneurea;N-(β-Hydroxyethyl)-N,N′-ethylene urea;Ucar RD 65-2;N-(2-Hydroxyethyl)ethyleneurea;SR 511;Sartomer SR 511;SR 511A;NSC 5775;Norsocryl 101;N-(2-Hydroxyethyl)imidazolidin-2-one;3-(2-Hydroxyethyl)-2-imidazolidinone |
3699-54-5 | Inquiry | |
1H-Isoindole-1,3(2H)-dione,4-amino-2-(2,6-dioxo-3-piperidinyl)- |
1H-Isoindole-1,3(2H)-dione,4-amino-2-(2,6-dioxo-3-piperidinyl)-;Phthalimide,3-amino-N-(2,6-dioxo-3-piperidyl)-;4-Amino-2-(2,6-dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione;4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione;CC 4047;Actimid;4-Amino-2-(2,6-dioxo-3-piperidinyl)isoindole-1,3-dione;Pomalidomide;4-Amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione;2-(2,6-Dioxopiperidin-3-yl)-4-amino-isoindole-1,3-dione;4-Amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione;Pomalyst;Imnovid;443912-23-0;443919-33-3 |
19171-19-8 | Inquiry | |
2'-Deoxyuridine |
Uridine,2′-deoxy-;2′-Deoxyuridine;Deoxyuridine;Uracil deoxyriboside;2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-β-D-erythro-pentofuranosyl)-;2,4(1H,3H)-Pyrimidinedione,1-(2-deoxy-β-D-ribofuranosyl)-;Deoxyribose uracil;2′-Desoxyuridine;1-(2-Deoxy-β-D-erythro-pentofuranosyl)uracil;NSC 23615;20649-53-0 |
951-78-0 | Inquiry | |
2,4(1H,3H)-Pyrimidinedione,1-b-D-arabinofuranosyl- |
2,4(1H,3H)-Pyrimidinedione,1-β-D-arabinofuranosyl-;Uracil,1-β-D-arabinofuranosyl-;1-β-D-Arabinofuranosyl-2,4(1H,3H)-pyrimidinedione;Spongouridine;Uracil arabinoside;1-β-D-Arabinofuranosyluracil;Arauridine;Uracil β-D-arabinofuranoside;Arabinosyluracil;Arabinofuranosyluracil;Spongouridin;Ara-U;NSC 68928;489-61-2;92418-86-5 |
3083-77-0 | Inquiry | |
2,4(1H,3H)-Pyrimidinedione,1-b-D-arabinofuranosyl-5-methyl- |
2,4(1H,3H)-Pyrimidinedione,1-β-D-arabinofuranosyl-5-methyl-;Thymine,1-β-D-arabinofuranosyl-;1-β-D-Arabinofuranosyl-5-methyl-2,4(1H,3H)-pyrimidinedione;Spongothymidine;Spongothymidin;Thymine arabinoside;1-β-D-Arabinofuranosylthymine;Arabinosylthymine;Ara-T;5-Methylarabinosyluracil;NSC 68929;1-β-D Arabinofuranosylthymine;Chembridge 5141213;2946-29-4 |
605-23-2 | Inquiry | |
2-Pyrrolidinecarbonitrile,1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- |
2-Pyrrolidinecarbonitrile,1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-,(2S)-;2-Pyrrolidinecarbonitrile,1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-,(2S)-;(2S)-1-[2-[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile;Vildagliptin;LAF 237;NVP-LAF 237;Galvus;Equa;DSP 7238;(S)-1-[2-[(3-Hydroxyadamant-1-yl)amino]acetyl]pyrrolidine-2-carbonitrile;(2S)-1-[2-[(3-Hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile;Xiliarx;Jalra;565453-38-5 |
274901-16-5 | Inquiry | |
3-Amino-2,6-piperidinedione hydrochloride |
24666-56-6 | Inquiry | ||
5H-Pyrrolo[3,4-b]pyrazine-5,7(6H)-dione,6-(5-chloro-2-pyridinyl)- |
5H-Pyrrolo[3,4-b]pyrazine-5,7(6H)-dione,6-(5-chloro-2-pyridinyl)-;6-(5-Chloro-2-pyridinyl)-5H-pyrrolo[3,4-b]pyrazine-5,7(6H)-dione;6-(5-Chloro-2-pyridinyl)-5,7-dioxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
43200-82-4 | Inquiry | |
7-Methoxy-1-naphthylacetonitrile |
1-Naphthaleneacetonitrile,7-methoxy-;7-Methoxy-1-naphthaleneacetonitrile;7-Methoxy-1-naphthylacetonitrile;1-Cyanomethyl-7-methoxynaphthalene;2-(7-Methoxy-1-naphthyl)acetonitrile;(7-Methoxynaphthalen-1-yl)acetonitrile;7-Methoxynaphthalene-1-acetonitrile;2-(7-Methoxynaphthalen-1-yl)acetonitrile |
138113-08-3 | Inquiry | |
7-methoxy-1-tetralone |
1(2H)-Naphthalenone,3,4-dihydro-7-methoxy-;3,4-Dihydro-7-methoxy-1(2H)-naphthalenone;7-Methoxy-1-tetralone;7-Methoxy-α-tetralone;7-Methoxy-3,4-dihydro-1(2H)-naphthalenone;7-Methoxytetralone;7-Methoxy-3,4-dihydro-2H-naphthalen-1-one;NSC 97611;7-Methoxy-1,2,3,4-tetrahydro-1-oxonaphthalene;7-Methoxy-1,2,3,4-tetrahydro-1-naphthalenone;7-Methoxytetralin-1-one |
6836-19-7 | Inquiry | |
7-methoxy-2-tetralone |
2(1H)-Naphthalenone,3,4-dihydro-7-methoxy-;3,4-Dihydro-7-methoxy-2(1H)-naphthalenone;7-Methoxy-2-tetralone;7-Methoxy-β-tetralone;7-Methoxy-3,4-dihydro-1H-naphthalen-2-one;7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-one;7-Methoxy-3,4-dihydronaphthalen-2(1H)-one;7-Methoxy-2-tetralinone |
4133-34-0 | Inquiry | |
Acetamide,N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]- |
Acetamide,N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-;Acetamide,N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-,(S)-;N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;U 100766;Linezolid;PNU 100766;Zyvox;Zyvoxid;N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide;Linox;Linospan;(S)-Linezolid;Lizolid;Lizoforce;Averozolid;Zyrox |
165800-03-3 | Inquiry | |
Adefovir |
Phosphonic acid,P-[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-;Phosphonic acid,[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-;P-[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid;9-(2-Phosphonylmethoxyethyl)adenine;PMEA;9-[2-(Phosphonomethoxy)ethyl]adenine;GS 0393;Adefovir;((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonicacid;[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]phosphonic acid;2-(6-Aminopurin-9-yl)ethoxymethylphosphonic acid |
106941-25-7 | Inquiry | |
Adefovir dipivoxil |
Propanoic acid,2,2-dimethyl-,1,1′-[[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene)] ester;Propanoic acid,2,2-dimethyl-,[[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]phosphinylidene]bis(oxymethylene) ester;GS 0840;Adefovir dipivoxil;Preveon;Hepsera;bis(POM)-PMEA;30: PN: WO2016077321 SEQID: 30 claimed sequence;[2-(6-Aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate |
142340-99-6 | Inquiry | |
Agomelatine |
Acetamide,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-;N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide;S 20098;N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide;Agomelatine;Valdoxan;N-[2-(7-Methoxynaphthalen-1-yl)ethyl]acetamide;AGO 178;Thymanax |
138112-76-2 | Inquiry | |
Astaxanthin |
β,β-Carotene-4,4′-dione,3,3′-dihydroxy-,(3S,3′S)-;β-Carotene-4,4′-dione,3,3′-dihydroxy-,all-trans-;Astaxanthin;(3S,3′S)-3,3′-Dihydroxy-β,β-carotene-4,4′-dione;Ovoester;Astaxanthin,all-trans-;(3S,3′S)-Astaxanthin;all-trans-Astaxanthin;trans-Astaxanthin;(3S,3′S)-all-trans-Astaxanthin;(3S,3′S)-Astaxanthin;Carophyll Pink;Natupink;BioAstin oleoresin;BioAstin;Lucantin Pink;AstaREAL;NatuRose;AstaXin;Astared;Astots 10O;Astots 5O;Aquasta;(S,S)-Astaxanthin;Astabio AR 5;AstaREAL A1010;Puresta W 05;Astareal ACT;Astacarox;Astabio AR 1;Astax S;Astots ST;all-trans-(3S,3′S)-Astaxanthin;Sunactive AX 310;AstaZine;Astots AWS;Astots 50S;Astabio AP1;346585-67-9 |
472-61-7 | Inquiry | |
Bortezomib |
Boronic acid,B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Boronic acid,[3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-,[S-(R*,S*)]-;Boronic acid,[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-;B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid;PS 341;PS 341 (pharmaceutical);MG 341;LDP 341;Bortezomib;MLN 341;Velcade;NSC 681239;DPBA;Radiciol;PS 314;Brotezamide;197730-97-5 |
179324-69-7 | Inquiry | |
Bupropion Hydrobromide |
1-Propanone,1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-,hydrobromide (1:1);1-Propanone,1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-,hydrobromide;Bupropion hydrobromide |
905818-69-1 | Inquiry |
CONTACT INFORMATION
Sign In for Details